COVID-19 Records

Attachment

Gates Package, p.483 · gates:exh:00162

Page text: p.483 · original PDF

Date
(unknown precision)
Type
attachment · document
Topics
Gates Foundation involvementVaccines
tential Scalebal Health 1d Dr. Carl ott Miller > Sizemore ff Murray a Kutlesic Johnston 11:40 A.M. - 12:30 P.M. Panel 4: Progress in HIV Prevention Science and Potential Scaleup Moderator: Trevor Mundel, MD, PhD, President, Global Health Division, BMGF Discussants Emilio A. Emini, PhD, Director, HIV, BMGF Carl W. Dieffenbach, PhD, Director, Division of AIDS (DAIDS), NIAID, NIH Nina Russell, MD, Deputy Director, HIV, BMGF Mary Marovich, MD, Director Vaccine Research Program, DAIDS, NIH Discussion to include: • Follow-up to RV144 • Next generation PrEP and microbicides • Breaking through the challenges of vaccine manufacture 12:30 P.M. - 12:45 P.M. Break 12:45 P.M. - 2:20 P.M. Working Group Lunches and Breakout Sessions HIV/AIDS Co-chairs: Dr. Emilio Emini, Dr. Nina Russell and Dr. Carl Dieffenbach Room 1G600 (1st Floor Skybox) Malaria Co-chairs: Dr. Lee Hall and Dr. Scott Miller Room 2G600 (2nd Floor Skybox) TB Co-chairs: Dr. Gilla Kaplan and Dr. Christine Sizemore Room 640 Maternal and newborn health Co-chairs: Dr. Tonse N.K. Raju and Dr. Jeff Murray Room 620/630 Child health and development Co-chairs: Dr. Dan Marks and Dr. Vesna Kutlesic Room 610 Pneumonia, enteric diseases, and indoor air pollution Co-chairs: Dr. Gail Rodgers, Dr. Josh Rosenthal and Dr. Linda Lambert Room 607 Contraceptive research Co-chairs: Dr. Dan Hartman and Dr. Dan Johnston Room 3G600 (3rd Floor Skybox)